Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine dose comparison in sedated critically ill ICU patients
ChiCTR-TRC-14004535Phase 4Completed
- Sponsor
- Shanghai General Hospital
- Start
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of dexmedetomidine in critical illness (2 arms), sponsored by Shanghai General Hospital. Primary endpoints: Ramsay score, heart rate and 3 more. Started May 2014; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
critical illness
Beyond the preview
Go deeper on ChiCTR-TRC-14004535.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-14004535.